Atlas Trials

An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects

Clinical trial NCT03084718 · COMPLETED

Trial details

NCT number
NCT03084718
Sponsor
Chiesi Farmaceutici S.p.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2017-07-28
Primary completion
2018-11-28
Enrollment
610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.